主动脉瘤的腔内隔绝术介入治疗  

The interventional therapy by endovascular graft exclusion for aortic aneurysm

作　　者：郝刚[1] 孔铭新[1] 李伟[1] 于曰俊[1] 赵廷常[1] 

机构地区：[1]山东省潍坊市人民医院介入放射科,山东潍坊261041

出　　处：《医学影像学杂志》2007年第10期1060-1062,共3页Journal of Medical Imaging

摘　　要：目的：讨论腔内人造血管隔绝术治疗主动脉瘤近期临床疗效。方法：4例肾下腹主动脉瘤和1例主动脉弓夹层动脉瘤病人接受腔内人造血管隔绝术治疗，术前均行彩超、三维重建螺旋CT检测。结果：术后即刻DSA造影显示：5例动脉瘤消失，近远端人造血管与主动脉结合处无内漏，腔内人造血管无移位，5例病人临床均获成功。术后3～6个月彩超及CT随访显示腔内人造血管无移位及内漏，动脉瘤残腔无增大及血流。结论：腔内人造血管隔绝术是一种创伤小、恢复快的治疗主动脉瘤的安全、有效的新方法，但远期疗效有待随访。Objective：To investigate the efficacy in the freafment of aortic aneursm using endovascular graft exclusion （EVE） in a shod-term.Methods：Four patients with aortic aneurysm infrarenal anettrysm and one with aortic arch anettrysm were treated with EVE. All patients were detected by CDFI and three-dimensional reconstruction of spiral CT before operation.Results：Instant postoperative DSA displayed： Five aneurysrm disappeared; There was no internal hemorrhage at the conjunctions between arteriae aorta and blood vessel prosthesis（BVP） and no dislocations of intraoavitary BVP. All patients were treated successfully. We followed up all patients by CDFI and CT for 3 - 6 months after operation. There were no aversion, intor hemorrhage in intracavitary BVP, and no dilation and bloodstream in remnant cavity of aneur,F=an. Conduslon：EVE is a new method to treat aortic aneurysm, which is safety and effective with limited trauma and rapid recovery. But the prostecdtive efficacy of EVE should be verified by follow-up.

关 键 词：主动脉瘤 介入放射学 夹层 腔内隔绝术 支架-人造血管 

分 类 号：R543.1[医药卫生—心血管疾病] R815[医药卫生—内科学]